New drug aims to tame dangerous blood fats
NCT ID NCT07349615
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new medicine called SHR-1918 for people with high triglycerides, a type of blood fat that can raise heart risk. About 360 adults will get either the drug or a placebo for 48 weeks to see if it safely lowers fat levels. The goal is to control the condition, not cure it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhongshan Hospital
RECRUITINGShanghai, Shanghai Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Plant-Based protein switch reshape your metabolism?
- Fish oil pills put to the test: can they tame high triglycerides?
- Weekly shot aims to tame dangerous fat levels in the blood
- Could ozempic stop pancreatitis from coming back?
- New shot aims to tame dangerous fat levels in blood
- New drug RBD5044 aims to lower high triglycerides in phase 2 trial